We provide you with 20 years of free, institutional-grade data for ICVX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ICVX. Explore the full financial landscape of ICVX stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Simpson Adam K. | Sale | -15,000 | $15.29 | $229,386 | 2024-02-02 |
| Simpson Adam K. | Derivatives Exercise | 15,000 | 2024-02-02 | ||
| Simpson Adam K. | Derivatives Exercise | 98,016 | 2024-01-23 | ||
| Kanesa-thasan Niranjan | Sale | -106,373 | $15.7 | $1,670,460 | 2024-01-05 |
| Kanesa-thasan Niranjan | Derivatives Exercise | 106,373 | 2024-01-05 | ||
| Simpson Adam K. | Sale | -15,000 | $15.67 | $235,088 | 2024-01-04 |
| Simpson Adam K. | Derivatives Exercise | 15,000 | 2024-01-04 | ||
| Simpson Adam K. | Derivatives Exercise | 165,917 | 2023-12-22 | ||
| Simpson Adam K. | Sale | -152,205 | $15.46 | $2,352,648 | 2023-12-22 |
| Russo Thomas Joseph | Sale | -15,183 | $15.46 | $234,685 | 2023-12-22 |
| Kanesa-thasan Niranjan | Sale | -11,884 | $15.46 | $183,692 | 2023-12-22 |
| Cearley Cassia | Sale | -7,934 | $15.46 | $122,637 | 2023-12-22 |
| Cearley Cassia | Sale | -8,759 | $16.01 | $140,190 | 2023-12-15 |
| Simpson Adam K. | Derivatives Exercise | 3,000 | 2023-08-01 | ||
| Cearley Cassia | Sale | -1,888 | $8.86 | $16,731 | 2023-08-01 |
| Kanesa-thasan Niranjan | Sale | -3,323 | $8.86 | $29,447 | 2023-08-01 |
| Simpson Adam K. | Sale | -11,788 | $8.86 | $104,459 | 2023-08-01 |
| Russo Thomas Joseph | Sale | -3,066 | $8.86 | $27,169 | 2023-08-01 |
| Holtzman Douglas | Sale | -16,356 | $8.74 | $142,973 | 2023-07-03 |
| Holtzman Douglas | Derivatives Exercise | 16,356 | 2023-07-03 | ||
| Cearley Cassia | Sale | -10,000 | $10 | $100,000 | 2023-05-25 |
| Holtzman Douglas | Sale | -20,443 | $6.08 | $124,263 | 2023-04-05 |
| Holtzman Douglas | Derivatives Exercise | 20,443 | 2023-04-05 | ||
| Cearley Cassia | Sale | -5,000 | $7.75 | $38,737 | 2023-03-08 |
| Simpson Adam K. | Derivatives Exercise | 10,677 | 2023-02-16 | ||
| Holtzman Douglas | Sale | -4,871 | $10.69 | $52,084 | 2023-02-15 |
| Bekiroglu Elizabeth | Sale | -5,922 | $10.69 | $63,322 | 2023-02-15 |
| Russo Thomas Joseph | Sale | -1,902 | $10.69 | $20,337 | 2023-02-15 |
| Simpson Adam K. | Sale | -7,506 | $10.69 | $80,259 | 2023-02-15 |
| Kanesa-thasan Niranjan | Sale | -1,794 | $10.69 | $19,183 | 2023-02-15 |
| Cearley Cassia | Sale | -1,660 | $10.69 | $17,750 | 2023-02-15 |
| Cearley Cassia | Derivatives Exercise | 25,102 | 2023-01-31 | ||
| Simpson Adam K. | Derivatives Exercise | 13,073 | 2023-01-27 | ||
| Simpson Adam K. | Derivatives Exercise | 14,369 | 2022-12-23 | ||
| Simpson Adam K. | Sale | -66,764 | $8.96 | $598,406 | 2022-12-23 |
| Holtzman Douglas | Sale | -19,648 | $11.14 | $218,963 | 2022-12-16 |
| Bekiroglu Elizabeth | Sale | -1,813 | $4.87 | $8,835 | 2022-09-09 |
| Simpson Adam K. | Sale | -11,377 | $7.11 | $80,863 | 2022-08-02 |
| Richardson Charles E | Sale | -2,218 | $7.11 | $15,765 | 2022-08-02 |
| Holtzman Douglas | Sale | -10,375 | $7.11 | $73,741 | 2022-08-02 |
| Russo Thomas Joseph | Sale | -2,959 | $7.11 | $21,031 | 2022-08-02 |
| Kanesa-thasan Niranjan | Sale | -3,245 | $7.11 | $23,064 | 2022-08-02 |
| Cearley Cassia | Sale | -1,812 | $7.11 | $12,879 | 2022-08-02 |
| Simpson Adam K. | Derivatives Exercise | 7,185 | 2022-07-06 | ||
| RA CAPITAL MANAGEMENT, L.P. | Grant, award...etc | 5,543 | 2022-06-14 | ||
| MCDADE MARK | Grant, award...etc | 5,543 | 2022-06-14 | ||
| Shiver John W. | Grant, award...etc | 2,399 | 2022-06-14 | ||
| FIELDS HEIDI | Grant, award...etc | 5,543 | 2022-06-14 | ||
| Wassil Jim | Grant, award...etc | 11,087 | 2022-06-14 | ||
| Veneman Ann M | Grant, award...etc | 5,543 | 2022-06-14 | ||
| MCDADE MARK | Open Market Purchase | 42,225 | $7.1 | 2022-04-05 | |
| Simpson Adam K. | Derivatives Exercise | 4,789 | 2022-03-30 | ||
| RA CAPITAL MANAGEMENT, L.P. | Open Market Purchase | 8,900 | $4.75 | 2022-03-30 | |
| RA CAPITAL MANAGEMENT, L.P. | Open Market Purchase | 175,318 | $4.53 | 2022-03-30 | |
| Cearley Cassia | Derivatives Exercise | 35,137 | 2022-03-22 | ||
| Cearley Cassia | Sale | -10,000 | $17.13 | $171,300 | 2022-03-09 |
| Richardson Charles E | Derivatives Exercise | 72,561 | 2022-02-16 | ||
| Cearley Cassia | Grant, award...etc | 21,256 | 2022-02-14 | ||
| Bekiroglu Elizabeth | Grant, award...etc | 82,992 | 2022-02-14 | ||
| Richardson Charles E | Grant, award...etc | 15,942 | 2022-02-14 | ||
| Holtzman Douglas | Grant, award...etc | 19,485 | 2022-02-14 | ||
| Russo Thomas Joseph | Grant, award...etc | 17,714 | 2022-02-14 | ||
| Kanesa-thasan Niranjan | Grant, award...etc | 19,485 | 2022-02-14 | ||
| Simpson Adam K. | Grant, award...etc | 75,578 | 2022-02-14 | ||
| Kanesa-thasan Niranjan | Derivatives Exercise | 52,752 | 2022-02-04 | ||
| Simpson Adam K. | Derivatives Exercise | 90,693 | 2022-01-28 | ||
| Shiver John W. | Grant, award...etc | 8,500 | 2022-01-05 | ||
| Cearley Cassia | Derivatives Exercise | 22,598 | 2021-11-17 |
The information provided in this report about ICVX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Icosavax(NASDAQ:ICVX) 
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-A12, an respiratory syncytial ...
Website: https://icosavax.com/
Founded: 2017
CEO: Adam Simpson
Sector: Healthcare
Industry: Biotechnology